MedTrace Logo

Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)

NCT00664807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1023

Last updated 2009-08-25

No results posted yet for this study

Summary

To generate a list of potential genetic markers that correlate with an increased risk of life-threatening arrhythmias.

To evaluate ECG-based risk markers such as heart rate variability and T-wave Alternans for their association with arrhythmic events.

Conditions

  • Death, Sudden, Cardiac
  • Ventricular Fibrillation
  • Tachycardia
  • Atrial Fibrillation
  • Sick Sinus Syndrome

Sponsors & Collaborators

  • Medtronic Corporate Technologies and New Ventures

    lead INDUSTRY

Principal Investigators

  • Eric Topol, M.D. · Scripps Translational Science Institute, La Jolla, CA USA

  • Robert Kowal, M.D.,Ph.D. · HeartPlace Baylor, Dallas, TX USA

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-04-30
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00664807 on ClinicalTrials.gov